T細胞白血病(T-Cell Leukemia):治療薬開発パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】T-Cell Leukemia - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
T-Cell Leukemia Overview 8
Therapeutics Development 9
Pipeline Products for T-Cell Leukemia – Overview 9
Pipeline Products for T-Cell Leukemia – Comparative Analysis 10
T-Cell Leukemia – Therapeutics under Development by Companies 11
T-Cell Leukemia – Therapeutics under Investigation by Universities/Institutes 12
T-Cell Leukemia – Pipeline Products Glance 13
Clinical Stage Products 13
Early Stage Products 14
T-Cell Leukemia – Products under Development by Companies 15
T-Cell Leukemia – Products under Investigation by Universities/Institutes 16
T-Cell Leukemia – Companies Involved in Therapeutics Development 17
Applied Immune Technologies Ltd 17
Astellas Pharma Inc. 18
Bristol-Myers Squibb Company 19
Celgene Corporation 20
iDD biotech SAS 21
Kyowa Hakko Kirin Co., Ltd. 22
MediGene AG 23
Nippon Kayaku Co., Ltd. 24
Pfizer Inc. 25
Pharmacyclics, Inc. 26
Sanofi 27
Stemline Therapeutics, Inc. 28
Theravectys S.A. 29
Tolero Pharmaceuticals, Inc. 30
T-Cell Leukemia – Therapeutics Assessment 31
Assessment by Monotherapy Products 31
Assessment by Target 32
Assessment by Mechanism of Action 34
Assessment by Route of Administration 36
Assessment by Molecule Type 38
Drug Profiles 40
AGS-67E – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
alemtuzumab – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
Antibody to Inhibit HLA-A2 for Neurology, Infectious Diseases and T-Cell Leukemia – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
BMS-906024 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Cell Therapy to Target CD38 for cancer – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
IDD-003 – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
INA-01 – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
lenalidomide – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
MMIG-202 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
mogamulizumab – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Monoclonal Antibodies to Antagonize TCR for Leukemia and Autoimmune Disease – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
Monoclonal Antibody to Target CCR9 for T Lymphoblastic Leukemia – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
NK-314 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
Oncolytic Virus to Target Glycoprotein gp160 for T-cell Leukemia – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
PCI-34051 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
PF-03084014 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
SL-101 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Synthetic Peptide for Oncology and Male health – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
THV-02 – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
TP-0903 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
T-Cell Leukemia – Recent Pipeline Updates 68
T-Cell Leukemia – Dormant Projects 85
T-Cell Leukemia – Discontinued Products 86
T-Cell Leukemia – Product Development Milestones 87
Featured News & Press Releases 87
Feb 04, 2015: THERAVECTYS Obtains Orphan Drug Designation from the European Medicines Agency for Its Lentiviral Vector-Based Therapeutic Vaccine against Adult T-Cell Leukemia and Lymphoma 87
Dec 18, 2014: Approval for Additional Indication for Chemotherapy-Native CCR4-positive ATL of Mogamulizumab 88
Sep 29, 2014: Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study 88
Aug 23, 2012: Kyowa Hakko Kirin Initiates Pivotal Phase II Trial Of Mogamulizumab In Patients With Adult T-cell Leukemia-Lymphoma In US And Europe 89
Jul 19, 2012: Application Seeking Approval for Additional Indication for ATL, PTCL and CTCL of Mogamulizumab 89
May 29, 2012: Kyowa Hakko Kirin Launches POTELIGEO Injection In Japan 90
Jan 25, 2012: Study Shows Leukemia Drug Kills Cancerous T-cells While Sparing Normal Immunity 90
Dec 07, 2010: Kyowa Hakko Kirin Announces Results From Japan Phase II Clinical Trial Of KW-0761 In Adult T-Cell Leukemia-Lymphoma 91
Appendix 92
Methodology 92
Coverage 92
Secondary Research 92
Primary Research 92
Expert Panel Validation 92
Contact Us 92
Disclaimer 93


【レポート販売概要】

■ タイトル:T細胞白血病(T-Cell Leukemia):治療薬開発パイプライン動向(2015年上半期版)
■ 英文:T-Cell Leukemia - Pipeline Review, H1 2015
■ 発行日:2015年2月24日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6280IDB
■ 調査対象地域:グローバル
  • デジタルパソロジーの世界市場:スキャナー、ソフトウェア、通信システム、ストレージシステム
    The global digital pathology market is expected to reach USD 679.1 Million by 2021 from USD 384.3 Million in 2016, growing at a CAGR of 12.1% from 2016 to 2021. The global digital pathology market is segmented on the basis of product, type, end-users and application. By product, the market is segmented into scanners, software, communication system and storage systems. The scanners segment is estim …
  • ビルエネルギー管理サービスのインド市場2016-2020
    About Building Energy Management Services BEM services refer to dedicated energy solutions provided to end-users in terms of energy savings and optimization. These services include the installation of an energy-efficient product, maintenance of existing machinery to reduce consumption, and concerted consulting in the forms of energy audits, monitoring, and control. Technavio’s analysts forecast th …
  • オンハイウェイ車両向けディーゼルパーティキュレートフィルターの世界市場予測(~2025年)
    “Increasing focus on emission regulation is expected to fuel the demand for diesel particulate filter”The OE DPF market is projected to grow at a CAGR of 11.29% during the forecast period and is projected to reach a market size of USD 24.81 billion by 2025, from an estimated market size of USD 10.55 billion in 2018. The DPF aftermarket is projected to grow at a CAGR of 3.89% during the forecast pe …
  • 世界のLTEベースステーション(eNodeB)市場動向(2012-2016)
    TechNavio's analysts forecast the Global LTE Base Station (eNodeB) market to grow at a CAGR of 49.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the inexorable rise of data. The Global LTE Base Station (eNodeB) market has also been witnessing the deployment in the re-farmed spectrum. However, the spectrum fragmentation could pose a challenge to th …
  • 電動式ショベルの世界市場
    About Electric Shovel An electric shovel is a type of bucket-equipped heavy machinery, which acts as a necessary equipment in activities related to the mining, digging, and loading of earth or fragmented rock. It is a modified steam shovel that operates in a similar fashion. Although the main purpose of shovels is to excavate and remove overburden in open-cut mining operations, it may also be used …
  • 実験室情報管理システム(LIMS)の世界市場予測(~2021年)
    The global laboratory information management system (LIMS) market is expected to reach USD 901.6 Million by 2021 from an estimated value of USD 634.0 Million in 2016 growing at a CAGR of 7.3% during the forecast period. The LIMS market is segmented on the basis of product type, deployment model, component, industry, and region. Based on product type, the market is segmented into broad-based LIMS a …
  • 恐怖症(フォビア):グローバル臨床試験動向(2014年上半期)
    Phobia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Phobia Global Clinical Trials Review, H1, 2014" provides data on the Phobia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Phobia It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction acr …
  • 世界の永久磁石市場2015
    The Global Permanent Magnets Industry Report 2015 is a professional and in-depth study on the current state of the Permanent Magnets industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Permanent Magnets market analysis is provided for the international markets including development trends, competitive …
  • アクティブ防護システムの世界市場予測(~2022)
    The active protection system market is projected to grow from USD 2.84 Billion in 2016 to USD 4.15 Billion by 2022, at a CAGR of 6.50% during the forecast period. Factors such as modernization of armed forces, rise in asymmetric warfare, and rising need for security from different types of weapon systems are expected to drive the market during the forecast period. The use of active protection syst …
  • MDI/TDI/ポリウレタンの世界市場予測(~2021年)
    MarketsandMarkets projects that the market for MDI, TDI, and polyurethane will grow from an estimated USD 69.28 Billion in 2016 to USD 90.34 Billion by 2021, at a CAGR of 5.45%. This market is growing because of the increase in demand for polyurethane from various end-use industries such as construction, automotive, and electronics. This growth in the consumer industry is expected to drive the dem …
  • PET 包装の世界市場2016-2020
    About PET Packaging Many new trends have emerged in the market such as the availability of hot-filling products in PET bottles and aseptic cold-filling PET bottles, which increase the shelf life of the products even if they are not kept at the optimum conditions. Recycling PET for re-use after sorting, cleaning, and transforming PET containers is also becoming popular in the market. Technavio’s an …
  • ガストリンの市場別医療検査数および販売予測
    This new report from Venture Planning Group provides analysis of Gastrin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing   - Hospitals - Commercial/Private Laboratories POC …
  • OCTG(油井管)の世界市場2016-2020
    About OCTG The global oil country tubular goods market pertains to the family of consumables consisting of drill pipe, casing, and tubing that are extensively utilized in the global oil and gas operations. They refer to a class of steel pipe products that have varied applications across the upstream oil and gas industry. These goods are seamless or welded; however, a new segment of pipes is slowly …
  • 高純度石英の世界市場2018-2022
    About High Purity Quartz High purity quartz, also known as HPQ, is made up of silica and oxygen and is one of the most common minerals on Earth. Quartz with more than 99% silicon dioxide is considered as high purity quartz. This high- grade quartz is the purest form of quartz. Technavio’s analysts forecast the global high purity quartz market to grow at a CAGR of 6.11% during the period 2018-2022. …
  • 世界の新生児マススクリーニング検査市場(~2019)
    The global newborn screening market is categorized on the basis of test type, technology, product, and geography. The mass spectrometry market is expected to register the highest growth rate in the newborn screening market by technology, during the forecast period. This high growth is attributed to various nations opting for expanded newborn screening. Tandem mass spectrometry is a fundamental ins …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。